Guru Ownership Trend
Guru Analysis for Generate Biomedicines, Inc. (GENB)
Generate Biomedicines, Inc. (GENB), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $6.79 M.
Top institutional holders include Catherine Wood and Paul Tudor Jones.
Institutional sentiment is currently Bullish. This is evidenced by a $6.53 M net inflow during the quarter.
Recent activity highlights Catherine Wood who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Generate Biomedicines, Inc. (GENB)
Major holders include Catherine Wood ($6.23 M), Paul Tudor Jones ($297,913). According to the latest reported data, 2 tracked investment managers collectively hold approximately 522,241 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $6.53 M, with 2 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in GENB during the most recent reporting period.
Yes, 2 managers opened new positions in GENB, and 0 increased their existing holdings. The total reported buy value was $6.53 M.